Pyruvate kinase isozymes and regulation There are four isoenzymes of - PowerPoint PPT Presentation

Nov 23, 2023 •729 likes •774 views

Pyruvate kinase isozymes and regulation There are four isoenzymes of PK: PKL (liver) and PKR (erythrocytes) are produced from PKLR gene PKM1 (muscle an brain) and PKM2 (fetal and most tissues) produced from PKM gene. The PKLR are

Pyruvate kinase isozymes and regulation There are four isoenzymes of PK: PKL (liver) and PKR (erythrocytes) are produced from PKLR gene PKM1 (muscle an brain) and PKM2 (fetal and most tissues) produced from PKM gene. The PKLR are allosterically regulated: inhibited by phosphorylation by protein kinase A, ATP, acetyl-CoA, alanine, and long-chain fatty acids activated by F1,6-BP. The liver enzyme is also controlled at the level of synthesis. Increased carbohydrate ingestion induces the synthesis of PK.
Fetal PK In erythrocytes, the fetal PK isozyme has much greater activity than the adult isozymes. Fetal erythrocytes have lower concentrations of glycolytic intermediates including 1,3BPG, (and 2,3BPG)

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

PSYCHO-SOCIAL EFFECTS OF HAVING A DISEASE LIKE PYRUVATE KINASE DEFICIENCY A PATIENT PERSPECTIVE 6

PSYCHO-SOCIAL EFFECTS OF HAVING A DISEASE LIKE PYRUVATE KINASE DEFICIENCY A PATIENT PERSPECTIVE 6 th EUROPEAN SYMPOSIUM ON RARE ANAEMIAS 1 st Dutch-Belgian meeting for patients and health professionals 21 st - 22 nd November 2015 Amsterdam - The

488 views • 19 slides

Pyruvate Kinase Deficiency Natural History Study Rachael Grace, MD, MMSc On behalf of the PKD

Pyruvate Kinase Deficiency Natural History Study Rachael Grace, MD, MMSc On behalf of the PKD NHS Investigators Assistant Professor, Harvard Medical School Director, Hematology Clinic, Boston Childrens Hospital, MA, USA 6 th EUROPEAN

681 views • 24 slides

of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FT-4202, an Allosteric

Phase 1 Single and Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FT-4202, an Allosteric Activator of Pyruvate Kinase-R, in Healthy and Sickle Cell Disease Subjects Theodosia A. Kalfa, MD,

507 views • 15 slides

Protein Kinase C- ( PKC- ) Inhibition: A Promise not yet Fulfilled Ruboxistaurin, an oral

Protein Kinase C- ( PKC- ) Inhibition: A Promise not yet Fulfilled Ruboxistaurin, an oral PKC- , was withdrawn on March 15, 2007 by Eli Lilly Dual Inhibition of Classical Protein Kinase C- and Protein Kinase C- Isoforms Protects

415 views • 13 slides

IMPROVED STUDIES ON MALIGNANCIES WITH A NOVEL PROLIFERATION BIOMARKER - Thymidine Kinase 1

IMPROVED STUDIES ON MALIGNANCIES WITH A NOVEL PROLIFERATION BIOMARKER - Thymidine Kinase 1 AROCELL TK 210 ELISA 1 AGENDA 1 Proliferation Biomarkers 2 Thymidine Kinase 1 as a Tumor Biomarker 3 Thymidine Kinase 1 in the Study of Hematological

500 views • 37 slides

Addressing Key Mechanisms of Tumor Drug Resistance July 2018 Kinase switch control inhibitors

Addressing Key Mechanisms of Tumor Drug Resistance July 2018 Kinase switch control inhibitors for tumor- targeted and immune-targeted cancer therapies Our Proprietary Kinase Switch Control Platform Kinase Switched Off Kinase Switched

401 views • 16 slides

Driver Kinase Fusions in Cancer TCGA 4 th Annual Scientific Symposium May 12 th , 2015 Nicolas

Driver Kinase Fusions in Cancer TCGA 4 th Annual Scientific Symposium May 12 th , 2015 Nicolas Stransky, PhD What are Kinase Fusions? KIF5B-RET Fusion Genomic instability, a hallmark of cancer, can result in chromosomal translocations or

212 views • 17 slides

EGF receptor transactivation is crucial for cholinergic MAP kinase signaling in human

1st Electronic Conference on Molecular Science EGF receptor transactivation is crucial for cholinergic MAP kinase signaling in human keratinocytes Wymke Ockenga , Sina Khne, Antje Banning and Ritva Tikkanen Institute of Biochemistry,

298 views • 14 slides

Abietane Diterpenoids from Plectranthus spp. as a potential new class of Protein Kinase C

Abietane Diterpenoids from Plectranthus spp. as a potential new class of Protein Kinase C Modulators Patrcia Rijo 1,2* , Vera M. S. Isca 1,2 , Epole Ntungwe 1 , Cludia Bessa 3 , Carlos A.M. Afonso 2 , Luclia Saraiva 3 1 Center for Research in

538 views • 22 slides

Pantothenate kinase isoforms as collateral lethality targets in Glioblastoma Multiforme NAME OF

Pantothenate kinase isoforms as collateral lethality targets in Glioblastoma Multiforme NAME OF STUDENT On-Topic Candidacy Exam Adviser: Dr. XXXXXX Concomitant l loss o of p passeng nger ge genes es o occur with genomic c de deletion

637 views • 38 slides

Elucidating cell-to-cell variability in phosphorylation of the ERK MAP kinase Sarah Filippi

Elucidating cell-to-cell variability in phosphorylation of the ERK MAP kinase Sarah Filippi Imperial College London Theoretical Systems Biology Group 20/02/2013 The ERK MAP pathway In eukaryotes Mitogen-activated protein (MAP) kinases

411 views • 29 slides

Substrate Enhancement Therapy With Deoxycytidine and Thymidine in Patients With Thymidine Kinase

Substrate Enhancement Therapy With Deoxycytidine and Thymidine in Patients With Thymidine Kinase 2 Deficiency UMDF Power Surge 2020 Virtual Conference Michio Hirano, Cristina Domnguez-Gonzlez, Carmen Paradas, Marcos Madruga, Andres

266 views • 13 slides

A First-in-class Phase 1 Dose-escalation Study of the Novel Oral ERK 1/2 Kinase Inhibitor BVD-523

A First-in-class Phase 1 Dose-escalation Study of the Novel Oral ERK 1/2 Kinase Inhibitor BVD-523 (ulixertinib) in Patients with Advanced Solid Tumors Jeffrey R. Infante, Filip Janku, Anthony W. Tolcher, Manish Patel, Ryan J. Sullivan, Keith T.

227 views • 21 slides

Progress on the co-crystallization of Thermoplasma acidophilum nucleoside kinase (TaNK) with

Progress on the co-crystallization of Thermoplasma acidophilum nucleoside kinase (TaNK) with substrates Jessica Yoo Columbus Lab CSS Symposium 1 Protein Misannotation High as for some protein families 1 80% Accuracy

170 views • 12 slides

LATITUDE-TIMI 60 L osm A pimod T o I nhibi T p38 MAP kinase as a therape U tic target and mo D ify

LATITUDE-TIMI 60 L osm A pimod T o I nhibi T p38 MAP kinase as a therape U tic target and mo D ify outcomes after an acute coronary syndrom E NCT02145468 (www.clinicaltrials.gov) Michelle L. ODonoghue, MD MPH On behalf of the LATITUDE-TIMI 60

510 views • 21 slides

ACALABRUTINIB IN MCL Simon Rule Professor of Clinical Haematology Consultant Haematologist

ACALABRUTINIB IN MCL Simon Rule Professor of Clinical Haematology Consultant Haematologist Derriford Hospital and Peninsula Medical School Plymouth UK BRUTON S TYROSINE KINASE (BTK): A CRITICAL KINASE FOR LYMPHOMA CELL SURVIVAL AND

878 views • 24 slides

20.201 Mechanisms of Drug Action Introduction 4 Sept 2013 Instructors Prof. Peter Dedon Prof.

20.201 Mechanisms of Drug Action Introduction 4 Sept 2013 Instructors Prof. Peter Dedon Prof. Steven Tannenbaum Dr. Mark Murcko Dr. Charles Knutson Guest lecturers Dr. Bernard Fermini, Pfizer Dr. Keith Hoffmaster, Novartis Dr. Tess

477 views • 24 slides

About our Speaker Name: Dr. Dhanasekaran Shanmugam, Ph.D. Where does he work Biochemical Sciences

About our Speaker Name: Dr. Dhanasekaran Shanmugam, Ph.D. Where does he work Biochemical Sciences Division, National Chemical Laboratory, Pune. What does he do Biological studies and drug discovery in malaria and other tropical infectious disease

353 views • 24 slides

Rimicaris shrimp at NW Eifuku (Pacific Rim of Fire) Shrimp ( Cypridina hilgendorfii ) uses

Rimicaris shrimp at NW Eifuku (Pacific Rim of Fire) Shrimp ( Cypridina hilgendorfii ) uses bioluminescent vomit to avoid preda6on 41 st SaasFee course from Planets to Life 39 April 2011 Lecture 5 Origin of Life and its Early Evolu6on on

969 views • 76 slides

et modes lmentaires Stefan Schuster Friedrich Schiller University Jena Dept. of

Rseaux mtaboliques et modes lmentaires Stefan Schuster Friedrich Schiller University Jena Dept. of Bioinformatics Introduction Analysis of metabolic systems requires theoretical methods due to high complexity Major challenge:

768 views • 63 slides

Mercury Compounds in Aquatic Systems and Their Relevance to Coal Production Ryan Wicks 14

Mercury Compounds in Aquatic Systems and Their Relevance to Coal Production Ryan Wicks 14 October 2014 Presentation Overview Background Types and toxicity Why Hg compounds are an emerging concern: bioaccumulation in seafood and

457 views • 41 slides

PARP Inhibition in Pancreatic Cancer; Other Investigational Strategies Eric Van Cutsem, MD, PhD

PARP Inhibition in Pancreatic Cancer; Other Investigational Strategies Eric Van Cutsem, MD, PhD Professor of Medicine Digestive Oncology University Hospital Leuven Leuven, Belgium PARP inhibitors and other novel agents Investigational

437 views • 26 slides

Network modularity, currency metabolites and graph representations of metabolism Petter Holme

metabolic networks, intro networks (physicist style?) modularity & currency metabolites subnetwork hierarchies Network modularity, currency metabolites and graph representations of metabolism Petter Holme KTH, CSC, Computational Biology

1.54k views • 106 slides

Discovery and analysis of biochemical subnetwork hierarchies October 6, 2003 Petter Holme

Discovery and analysis of biochemical subnetwork hierarchies October 6, 2003 Petter Holme Department of Physics, Ume a University, Ume a, Sweden NORDITA, Copenhagen, Denmark Mikael Huss SANS, NADA, Royal Institute of Technology,

314 views • 17 slides